Company eFFECTOR Therapeutics, Inc. Deutsche Boerse AG
Equities
LWK1
US28202V1089
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.075 EUR | +0.47% |
|
-8.12% | -88.97% |
Jul. 08 | EFFECTOR Therapeutics, Inc.(OTCPK:EFTR) dropped from S&P TMI Index | CI |
Jul. 02 | EFFECTOR Therapeutics, Inc.(OTCPK:EFTR) dropped from NASDAQ Composite Index | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mark Densel
PRN | Corporate Officer/Principal | - | 18-10-31 |
Mayank J. Gandhi
PRN | Corporate Officer/Principal | 47 | 22-09-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,716,409 | 4,567,493 ( 96.84 %) | 12,000 ( 0.2544 %) | 96.84 % |
Company contact information
eFFECTOR Therapeutics, Inc.
142 North Cedros Avenue Suite B
92075, Solana Beach
+
http://www.effector.com![address eFFECTOR Therapeutics, Inc.(LWK1)](https://cdn.zonebourse.com/static/address/127525341.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.60% | 127B | |
+25.24% | 117B | |
+25.56% | 27.77B | |
-20.55% | 20.44B | |
-14.36% | 16.62B | |
-13.64% | 15.92B | |
-46.67% | 14.94B | |
+12.24% | 14.74B | |
+56.61% | 14.38B |
- Stock Market
- Equities
- EFTR Stock
- LWK1 Stock
- Company eFFECTOR Therapeutics, Inc.